Detection of ZAP-70 in patients with chronic lymphocytic leukemia

Journal of B.U.ON.

Volumn 13, Issue 4, 2008, Pages 543-546

  Marjanovic, Goran ^a,c   Stanojevic, I ^b   Jankovic Velickovic, Lj ^a   Hubl, W ^c   Marjanovic, V ^b  

^a Clinical Centre Nis   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

^c Wilhellminen Spital der Stadt Wien ^*  (Serbia)

Author keywords

Chronic lymphocytic leukemia; Prognostic factors; ZAP 70

Indexed keywords

PROTEIN KINASE ZAP 70;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE EXACERBATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION;

ADULT; AGED; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 58149352603     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chen A, Apgar J, Hunth L et al. Zap 70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood 2005; 105: 2036-2041.
2. Hamblin TJ, Davis Z, Gardinger A, Oscier DG, Stevenson FK. Unmutated IgV(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848-1854.
3. Krober A, Seiler T, Benner A et al. V(H) mutation status, CD38 expression level, genomic aberration and survival in chronic lymphocytic leukemia Blood 2002; 100: 1410-1416.
4. Weistner A, Rosenwald A, Barry TS et al. Zap70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior outcome, and distinct gene expression profile. Blood 2003; 101: 4944-4951.
5. Matutes E, Owusu-Ankomah K, Morilla R et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8: 1640-1645.
6. Crespo M, Bosch E, Villamor N et al. Zap70 expression as a surrogate for immunoglobulin-variable region mutations in chronic lymphocytic leukemia. N Eng J Med 2003; 348: 1764-1775.
7. Best OG, Ibbotson RE, Parker AE, Davis AZ, Orchard JA, Oscier DG. ZAP-70 flow cytometry: a comparison of different antibodies, anticoagulants and methods of analysis. Cytometry 2006; 708: 235-241 (Part B).
8. Sheikholeslami MR, Jilani I, Keating M et al. Variations in the detection of ZAP-70 in chronic lymphocytic leukemia: comparison with IgVH mutation status. Cytometry Part B, 2006; 708: 270-275.
9. Goolsby C, Kuchinio M, Finn W, Peterson L. Expansions of clonal and oligoclonal T cells in B-cell chronic lymphocytic leukemia are primary restricted to the CD31CD81 T-cell population. Cytometry 2000; 42:188-195 (Communications in Clinical Cytometry).
10. Herishanu Y, Kay S, Rogowski O et al. T-cell ZAP-70 over-expression in chronic lymphocytic leukemia (CLL) correlates with CLL cell ZAP-70 levels, clinical stage and disease progression. Leukemia 2005; 19: 1289-1291.
11. Shenkin M, Maiese R. Use of blocking antibody method for the flow cytometric measurement of ZAP-70 in B-CLL. Cytometry 2006; 708: 251-258 (Part B).
12. Orchard JA, Ibbotson RE, Davis Z et al. ZAP-70 expression and prognosis in chronic lymphocytic leukemia. Lancet 2004; 363; 105-111.
13. Rassenti LZ, Huynh L, Toy TL et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Eng J Med 2004; 351: 893-901.
14. Zucchetto A, Bomben R, Dal BO M et al. ZAP-70 Expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgVh mutations. Cytometry 2006; 708: 284-292 (Part B).